期刊文献+

PTEN蛋白与雌激素受体α亚型在子宫内膜癌中的表达及意义 被引量:1

下载PDF
导出
摘要 目的检测子宫内膜癌组织中PTEN蛋白及雌激素受体亚型(ERα)表达并探讨其意义。方法采用免疫组织化学法检测30例子宫内膜癌、18例正常子宫内膜组织中PTEN蛋白及ERα的表达。结果子宫内膜癌组织中PTEN基蛋白缺失率为66.67%,高于正常子宫内膜组织(0)(P<0.05)。PTEN蛋白表达完全缺失在G2、G3级肿瘤高于G1级(P<0.05),PTEN蛋白缺失率均与肌层浸润、淋巴结转移及手术-病理分期无明显关系(P>0.05)。ERα在PTEN表达缺失的肿瘤中低于PTEN表达阳性者(P<0.05)。结论PTEN表达缺失与临床病理参数无关,蛋白表达缺失常发生细胞分化较差的子宫内膜癌。PTEN蛋白表达缺失与ERα表达水平有关。
出处 《河北医药》 CAS 2010年第1期42-43,共2页 Hebei Medical Journal
  • 相关文献

参考文献7

  • 1Parenti A, Leo G, Porzionato A, et al. Expression of survivin, p53, and caspase 3 in Barrett' s esophagus carcinogenesis. Hum Pathol, 2006,37 : 16 -22.
  • 2Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain,breast and prostate cancer. Science, 1997, 275 : 1943-1947.
  • 3Erkanli S, Kayaselcuk F, Kuscu E,et al. Expression of survivin, PTEN and p27 in normal hyperp lastic, and carcinomatous endometrium. Int J Gynecol Cancer,2006,16 : 1412-1418.
  • 4Han SY, Kato H, Kato S, et al. Function evaluation of PTEN missense mutations using in viro phosphoinositide phosphatase assay. Cancer Res, 2006,60:3147-3151.
  • 5Cerezo L, Cardenes H, Michael H. Molecular alterations in the pathogenesisof endometrial adenocarcinoma. Therapeutic implications. Clin Trains Oncol,2006,8:231-241.
  • 6Wilder JL, Shajahan S, Khattar NH, et al. Tamoxifen-associated malignant endometrial tumors : pathologic features and expression of hormone receptor estrogen-a, estrogen-β and progesterone; a case controlled study. Gynecologic Oncology ,2004,92:553-558.
  • 7张育军,魏丽惠,李小平,王建六.抑癌蛋白PTEN在雌激素和胰岛素样生长因子1诱导子宫内膜癌细胞ERK活化中的作用[J].癌症,2002,21(7):724-730. 被引量:6

二级参考文献14

  • 1[1]Bermont L,Fauconnet S,Lamielle F,et al.Cell associated insulin like growth factor binding proteins inhibit insulin like growth factor induced endometrial cancer cell proliferation [J]. Cel Mol Biol,2000,7:1173- 1182.
  • 2[2]Castoria G,Barone MV,Domenico MD,et al.Non transcriptional action of estradiol and progestin triggers DNA synthesis [J]. The EMBO J,1999,18:2500- 2510.
  • 3[3]Risinger JI,Hayes AK,Berchuck A, et al. PTEN/MMAC1 mutations in endometrial cancers [J]. Cancer Res, 1997, 57:4736- 4738.
  • 4[4]Mutter GL,Lin MC,Fitzgerald JT, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers [J]. J Nat Cancer Insti,2000,92:924- 931.
  • 5[5]Stambolic V,Tsao MS, Macpherson D, et al. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+ /- mice [J]. Oncogene, 2000, 234:567- 589.
  • 6[6]Yaginuma Y,Yamashita T,Ishiva T,et al.Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers [J]. Mol Carcinog,2000,2:110- 116.
  • 7[7]Migliaccio A,Domenico MD,Castoria G,et al.Tyrosine kinase/p21ras/MAP Kinase pathway activation by estradiol receptor complex in MCF-7 cells [J]. The EMBO J,1996,15:1292- 1300.
  • 8[8]Morrison DK.A MAPK scaffold of the Ras pathway [J]. J cell Sci,2001,114:1609- 1612.
  • 9[9]Simoncini T,Moghadam A,Brazil DP,et al.Interaction of estrogen receptor with the regulation subunit of phosphatidy linositol- 3-OH kinase [J]. Nature,2000,407:538- 541.
  • 10[10]Li J,Yen C,Liaw D,et al.PTEN,a putative protein tyrosine phosphatase gene mutated in human brain ,breast, and prostate[J]. Science,1997,5308:1943- 1947.

共引文献5

同被引文献6

  • 1Liu JL, Mao Z, La Fortune A, et al. Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide - 3-kinase signaling cascade. Cancer Res, 2007,67: 11054-11063.
  • 2Vitolo MI, Weiss MB,Szmacinski M,et al. Deletion of PTEN Promotes Tumorigenic Signaling, Resistance to Anoikis, and Altered Response to Chemotherapeutic Agents in Human Mammary Epithelial Cells. Cancer Res ,2009,69:8275-8283.
  • 3Ressel L, Millanta F, Caleri E, et al. Reduced PTEN Protein Expression and Its Prognostic Implications in Canine and Feline Mammary Tumors. Veterinary Pathology ,2009,46:860-868.
  • 4Nedelcu T, Kubista B, Koller A, et al. Livin and Bcl-2 expression in high- grade osteosarcoma. Cancer Res Clin Onco1,2008 ,134 :237-244.
  • 5王亚利,王中卫,王西京,金迎迎.Livin、survivin在乳腺癌中的表达及其与caspase-3和临床病理的相关性[J].西安交通大学学报(医学版),2009,30(4):466-469. 被引量:12
  • 6倪建华,辛军,伍伯聪,辛明华,吴文峰.Livin和PTEN在肾细胞癌中的表达及其临床意义[J].实用癌症杂志,2011,26(1):42-44. 被引量:8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部